ABUS vs COST · P/E 5.4, rev $6.2M vs P/E 55, rev $275.24B
Arbutus Biopharma Corp (ABUS) versus Costco Wholesale Corp (COST) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Costco Wholesale Corp (COST) is a discount stores company listed on US. It is led by Ron Vachris.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported COST revenue for 2025-08-31 was $275.24B. Net income was $8.10B. Revenue was up 8.2% from 2024-09-01 to 2025-08-31. COST currently screens at market cap $430.32B and trailing P/E 54.9.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. COST currently screens at market cap $430.32B and trailing P/E 54.9.
Not investment advice. Open the ABUS and COST stock pages for the full models.
Not investment advice.